Family Medicine · Odessa, TX
NPI
1821253162
Since 2008
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
6
Hospital affiliations
2487 E 11th St
Odessa, TX, 79761
Phone (432) 332-1386
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
25,457 services
Medicare patients, 2024
1,622
Average age 76
Drug cost, 2024
$4.7M
87,754 prescriptions
Company payments, 2025
$1,529
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scotty R Ortega was code 99308 (snf e&m), 8,027 times for 636 patients. In total Scotty R Ortega billed 25,457 services in 100 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 8,027 | 636 | $51.36 | $412K |
| 99232 Hospital E&M - Subsequent | Facility | 3,550 | 321 | $56.02 | $199K |
| 99233 Hospital E&M - Subsequent | Facility | 2,075 | 143 | $85.28 | $177K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 1,343 | 210 | $52.05 | $70K |
| 99214 Office E&M - Established | Office | 1,281 | 434 | $83.07 | $106K |
| 99308 SNF E&M | Office | 1,040 | 266 | $52.29 | $54K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 893 | 239 | $95.73 | $85K |
| 99213 Office E&M - Established | Office | 734 | 359 | $52.40 | $38K |
| 99309 SNF E&M | Facility | 718 | 273 | $73.04 | $52K |
| 99307 SNF E&M | Facility | 647 | 97 | $26.52 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 620 | 333 | $11.82 | $7,326 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 554 | 204 | $43.85 | $24K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 455 | 164 | $33.85 | $15K |
| 99223 Hospital E&M - Initial | Facility | 426 | 343 | $122.77 | $52K |
| 99306 SNF E&M | Facility | 325 | 275 | $125.73 | $41K |
By year: 2022 $1.1M for 19,109 services; 2023 $1.4M for 21,994 services; 2024 $1.5M for 25,457 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 42 | 37 | $3.41 | $143 |
| 0241U Infectious Agent Detection by DNA/RNA | 30 | 26 | $125.85 | $3,776 |
| 87428 Infectious Agent Detection by DNA/RNA | 13 | 13 | $68.88 | $895 |
Medicare prescription drug claims, 2024
In 2024, the drug Scotty R Ortega prescribed most often to Medicare patients was Atorvastatin Calcium, with 4,868 prescriptions and refills. In total Scotty R Ortega wrote 87,754 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 4,868 | 5,634 | 536 | $43K |
| Levothyroxine Sodium Generic | 3,547 | 3,980 | 363 | $32K |
| Gabapentin Generic | 2,979 | 3,136 | 304 | $29K |
| Lisinopril Generic | 2,962 | 3,359 | 309 | $20K |
| Amlodipine Besylate Generic | 2,907 | 3,277 | 351 | $18K |
| Donepezil Hcl Generic | 2,538 | 2,606 | 216 | $24K |
| Furosemide Generic | 2,328 | 2,450 | 257 | $11K |
| Memantine Hcl Generic | 2,032 | 2,058 | 160 | $52K |
| Metformin Hcl Generic | 1,839 | 2,158 | 202 | $11K |
| Potassium Chloride Generic | 1,795 | 1,898 | 257 | $26K |
| Sertraline Hcl Generic | 1,787 | 1,915 | 170 | $14K |
| Buspirone Hcl Generic | 1,776 | 1,865 | 204 | $27K |
| Eliquis Apixaban | 1,757 | 1,813 | 173 | $567K |
| Pantoprazole Sodium Generic | 1,661 | 1,981 | 279 | $15K |
| Trazodone Hcl Generic | 1,498 | 1,579 | 152 | $10K |
Brand drugs: 8,877 claims; generic drugs: 78,291 claims; opioid claims: 2,043.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scotty R Ortega $1,529 ($1,529 in general payments such as food, travel and fees) from 24 companies. The largest payer was Ardelyx, Inc. with $229.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 8 | $229 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $190 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $182 |
| Scpharmaceuticals Inc. SCPH | 1 | $125 |
| Lilly USA, LLC LLY | 4 | $84.72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78.58 |
| Lundbeck LLC | 3 | $73.91 |
| Novo Nordisk Inc NVO | 3 | $59.96 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $55.36 |
| Amgen Inc. AMGN | 3 | $50.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.